Meters & Monitors

Blood Glucose Meters Next Current Continuous Monitors Next Comparison of Available Monitors Next Various Future Monitors Next Improving Today's Meters Next Other Monitors Next Older Monitors

Future Monitoring

AiMedics Next A.Menarini Diagnostics Next Cybiocare OHD Next InLight Solutions Next Kumetrix Next LighTouch Medical Next NAS - iSense Next NIR Diagnostics Next Optiscan Next Orsense Next Pindi Products Next Sensors For Medicine and Science Next Sensys Medical Next Sentek Next Solianis Next Sontra Next SpectRx Next Synthetic Blood International Next Therasense Next Visual Pathways

Key
Non-Invasive Non-Invasive
Semi-Invasive Semi-Invasive
Surgical Surgical
Continuous Continuous

Synthetic Blood International - Implantable Glucose Biosensor Surgical Methods, Measures glucose by means of an implanted device.

Synthetic Blood International is a biomedical product development company specializing in creating innovative pharmaceuticals and medical devices in the fields of liquid ventilation, oxygen therapeutics, blood substitutes, and implanted glucose sensing. Many of their technology platforms are based on the pioneering research of Dr. Leland Clark, developer of the first heart-lung machine and the Clark oxygen and glucose biosensor electrodes.

Product development at SYBD is taking place on several innovative technological platforms, including the Glucose Biosensor. The implanted Glucose Biosensor continuously monitors blood glucose without the need for finger sticks. SYBD's implanted biosensor can be programmed to monitor blood glucose according to a predetermined schedule, thus eliminating problems of patient compliance. The sensor alarms for dangerous, life threatening conditions such as hypoglycemia.

The device is said to be made with similar materials you would find in a cardiac-pacemaker. New patents related to the sensor include an encased titanium battery and microprocessor as well a glucose oxidase enzyme system encapsulated in a semipermiable cellophane acetate membrane which provides continuous, accurate monitoring of blood glucose. Results are displayed as a digital readout in a wearable beeper-sized device that it hopes will have an implant life of over one year.